Fri.Jul 12, 2024

article thumbnail

STAT+: The biggest misconception about CTE, according to a leading brain trauma expert

STAT

This week, the late National Hockey League veteran Greg Johnson was diagnosed with chronic traumatic encephalopathy, or CTE. Johnson died by suicide five years ago at the age of 48, having played 14 seasons in the NHL. It’s the latest sign of the prevalence of CTE, a progressive neurodegenerative disease caused by repeated impacts to the head, in professional contact sports.

322
322
article thumbnail

BMS’ long-standing leukemia blockbuster stares down its first generic

PharmaVoice

Patent disputes in the U.S. and abroad have opened the door to new generics ready for launch as soon as September for BMS’ Sprycel.

265
265
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CAR-T therapy’s complications, as well as its benefits, become clearer in ‘flurry’ of cancer studies

STAT

Researchers were perplexed when the Food and Drug Administration announced it was investigating whether CAR-T therapy, one of the most effective treatments for blood cancers, could cause lymphoma. This was always a theoretical risk of genetically engineered therapies like CAR-T, but it never materialized in the decades after the technology’s birth.

268
268
article thumbnail

Proposed Medicare codes could lift digital health sector

pharmaphorum

A new payment policy proposal released by the Centers for Medicare and Medicaid Services (CMS) this week covers digital tools used for behavioural health, which could be a boost for the digital health sector.The Medicare Physician Fee Schedule (PFS) sets out the method of payment, rates, and codes for healthcare providers participating in Medicare, and is often used by the administration as an instrument to encourage some forms of healthcare intervention.

113
113
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Opinion: Unsettling truths about maternal mortality in the U.S.

STAT

Grave warnings of a crisis in maternal deaths are being slightly eroded by articles suggesting that advocates overreached and that the “crisis” was primarily a function of measurement error. Both sides are partially right, because measuring maternal mortality is uniquely challenging. The question at the heart of identifying a maternal death — “Would this person have died if she hadn’t been pregnant?

article thumbnail

Bristol Myers’ leukemia blockbuster set to face first generic rival

BioPharma Dive

Patent litigation has opened the door to generic copies of Bristol Myers’ Sprycel arriving in the U.S. as soon as September.

114
114

More Trending

article thumbnail

RPS asks for 'benefits and harms' of P med self-selection

The Pharmacist

The Royal Pharmaceutical Society (RPS) has called for evidence on the 'benefits and harms' of a 'facilitated self-selection model' for Pharmacy (P) medicines. Respondents have also been asked to suggest areas where further research is required. The RPS wants to hear from a wide range of pharmacists and pharmacy team members, patient representative bodies, employers, academics, […] The post RPS asks for 'benefits and harms' of P med self-selection appeared first on The Pharmacist.

97
article thumbnail

STAT+: Pharmalittle: We’re reading about a study of Ozempic and dementia, smaller PBMs, and more

STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up. We hope to catch up on our reading, promenade with the official mascots, and stop by a favorite festival. We may also hold another listening party, where the rotation will likely include this , this , this , this and this.

Diabetes 251
article thumbnail

At the Breaking Point: The Unsustainable Future of Government Drug Discount Programs

Drug Channels

Today’s guest post comes from Gavin Magaha, Senior Director of External Affairs and Policy at Kalderos. Gavin discusses the three key reasons for duplicate discounts between the 340B Drug Pricing Program and the Medicaid Drug Rebate Program. He then explains Oregon’s novel approach to fixing the problem. To learn more, register for Kalderos’ August 21, 2024, webinar: Revolutionizing Government Discount Programs: Why Traditional Methods Fail.

article thumbnail

Element Biosciences raises another massive round

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello! Today, we talk about an Illumina competitor’s newest influx of funding, Adam weighs in on Pfizer’s plan for a once-a-day GLP-1 pill, and more.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Antimicrobial Resistance and innovations shaping our future

Express Pharma

Antimicrobials in common practice are used to reduce the duration of illness and the chance of death from infections. They also prevent infections in people who are at high risk, such as patients undergoing surgery and those with weakened immune systems. They are a rare class of medication where the treatment of one patient can potentially affect the outcome of other patients and communities through the transmission of antimicrobial-resistant microbes.

article thumbnail

STAT+: Up and down the ladder: The latest comings and goings

STAT

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others.  That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.

217
217
article thumbnail

Pfizer selects once-daily GLP-1 for its obesity push

pharmaphorum

Pfizer is advancing on a broad front in its attempt to catch up with Novo Nordisk and Eli Lilly in the obesity drug category – but has now decided on a lead candidate.The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron that will start dose optimisation studies later this year.

101
101
article thumbnail

New pharmacy and medicines ministers confirmed

The Pharmacist

MP Stephen Kinnock will be the government minister with responsibility for pharmacy and general practice, under the title of minister of state for care, it has been announced. Meanwhile, minister of state for health Karin Smyth will take responsibility for medicines regulation, pricing and supply, as well as prescribing. Mr Kinnock, MP for Aberafan Maesteg, […] The post New pharmacy and medicines ministers confirmed appeared first on The Pharmacist.

90
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Coming soon: New EU Artificial Intelligence Act

pharmaphorum

Stay informed about the upcoming EU Artificial Intelligence Act, which will regulate AI use in compliance with EU standards. Learn how this legislation may impact your organisation's AI initiatives.

100
100
article thumbnail

Innovate UK grants £4m to four companies to evaluate biomarkers for dementia

Pharma Times

The progressive neurodegenerative disease affects more than 55 million people globally

118
118
article thumbnail

Streeting orders “raw and frank” investigation of NHS

pharmaphorum

New UK Health Secretary Wes Streeting orders a 'raw and frank' review of NHS to inform a new 10-year plan to fix it

105
105
article thumbnail

NHS rolls out “more convenient” Ocrevus injection for multiple sclerosis

Pharmaceutical Technology

The subcutaneous formulation of Roche’s blockbuster Ocrevus will cut hospital treatment time for patients.

Hospitals 111
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

LPC 200 Conclave to be held on July 21 in Chennai

Express Pharma

Live Pharma Coalition, a knowledge-sharing and networking forum is going to organise the LPC 200 Conclave in Chennai on July 21, 2024. The theme of the event is “Digital transformation across pharma: challenges and opportunities”. The event will include a keynote speech, panel discussion, networking session, poster presentation, and exhibition by health tech organisations.

89
article thumbnail

Connecting the clinical, regulatory, and commercial dots for rare diseases

pharmaphorum

Learn how to effectively connect the clinical, regulatory, and commercial aspects in the development of treatments for rare diseases. Discover strategies and insights for navigating the unique challenges of rare disease drug development.

article thumbnail

Celebrating the 2024 PharmaTimes MSEA and NIEA awards

Pharma Times

The awards celebrated both medical affairs and nursing professionals in the industry

114
114
article thumbnail

Penn pioneers a ‘one-pot platform’ to promptly produce mRNA delivery particles

Express Pharma

Imagine a scenario where a skilled hacker must upload critical software to update a central server and thwart a potentially lethal virus from wreaking havoc across a vast computer network. The programmer, armed with the lifesaving code, must navigate through treacherous territory teeming with adversaries, and success hinges on promptly getting a safe, stealthy delivery vehicle that can place the hacker exactly where they need to be.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Ipsen gains global rights to Foreseen Biotech’s FS001 ADC

Pharmaceutical Technology

Ipsen has entered an exclusive global licensing agreement with Foreseen Biotech for FS001, a potentially first-in-class ADC.

98
article thumbnail

DNA sequencer Element Bio raises $277m to take on Illumina

pharmaphorum

Element Bio’s bid to take on Illumina in the DNA sequencing market has been helped by an impressive $277m financing round

109
109
article thumbnail

UK Researchers developing new tetanus test to identify global immunity gaps

Pharma Times

The serious, rare condition is responsible for up to 7% of all neonatal deaths globally

article thumbnail

Appoint independent ‘medicine supply Tsar’, NPA tells government

The Pharmacist

The government should appoint an independent expert as a ‘medicine supply Tsar’ to tackle medicine shortages, the National Pharmacy Association (NPA) has said. This comes as a recent survey by the NPA and YouGov found that three in 10 patients have struggled to get their medicines in the last year. Some 28% of UK adults […] The post Appoint independent ‘medicine supply Tsar’, NPA tells government appeared first on The Pharmacist.

86
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Blow-fill-seal technology: Realizing a new frontier in sterile packaging

Outsourcing Pharma

Blow-fill-seal (BFS) technology has long been a cornerstone of pharmaceutical manufacturing, relied on for packaging sterile liquid medications, including but not limited to ophthalmic and respiratory drug products.

article thumbnail

UK needs Covid-style push on dementia drugs, says ex-head of vaccine taskforce

The Guardian - Pharmaceutical Industry

Kate Bingham says ageing population means tackling dementia must be treated as economic imperative A Covid-style effort is needed to ensure NHS patients are first in line for a new wave of dementia drugs, according to the former head of the UK’s vaccine taskforce. Kate Bingham is calling for the immediate recruitment of large numbers of patients to ensure that, as with Covid vaccines, the UK is a leading player in testing and launching drugs.

article thumbnail

NIH awards Cellibre $2M to advance sustainable cannabinoid ingredient production

Outsourcing Pharma

Cellibre, a leader in sustainable biochemical manufacturing, has secured a $2 million grant from the National Center for Complementary and Integrative Health (NCCIH) at the National Institutes of Health (NIH).

77
article thumbnail

EMCrit 379 – Procedural Sedation Part IV – the Critically Ill Patient and MidaKet

EMCrit Project

How do you sedate a critically ill patient for a procedure? EMCrit Project by Scott Weingart, MD FCCM.

93
article thumbnail

Lord Darzi tasked to lead investigation into ‘state of the NHS’

The Pharmacist

The health secretary has announced an ‘independent investigation’ into the ‘state of the NHS’, to be led by Professor Lord Ara Darzi. The findings of this ‘rapid’ investigation, which will be published in September, will feed into a new 10-year plan ‘to radically reform’ the NHS, for which patients and staff will be consulted ‘soon’. […] The post Lord Darzi tasked to lead investigation into ‘state of the NHS’ appeared first on The Pharmacist.

73